Kura Oncology Inc (KURA)
20.63
+0.04
(+0.22%)
USD |
NASDAQ |
May 03, 10:02
Kura Oncology Cash from Operations (TTM): -124.82M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -124.82M |
September 30, 2023 | -117.05M |
June 30, 2023 | -109.03M |
March 31, 2023 | -113.75M |
December 31, 2022 | -110.06M |
September 30, 2022 | -106.90M |
June 30, 2022 | -110.48M |
March 31, 2022 | -108.22M |
December 31, 2021 | -104.55M |
September 30, 2021 | -99.49M |
June 30, 2021 | -91.86M |
March 31, 2021 | -78.52M |
December 31, 2020 | -69.83M |
September 30, 2020 | -65.46M |
June 30, 2020 | -60.63M |
March 31, 2020 | -60.33M |
December 31, 2019 | -54.76M |
Date | Value |
---|---|
September 30, 2019 | -51.04M |
June 30, 2019 | -51.89M |
March 31, 2019 | -50.06M |
December 31, 2018 | -48.66M |
September 30, 2018 | -45.92M |
June 30, 2018 | -39.15M |
March 31, 2018 | -32.67M |
December 31, 2017 | -28.44M |
September 30, 2017 | -27.70M |
June 30, 2017 | -26.94M |
March 31, 2017 | -26.66M |
December 31, 2016 | -25.35M |
September 30, 2016 | -24.22M |
June 30, 2016 | -23.17M |
March 31, 2016 | -21.12M |
December 31, 2015 | -17.92M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-124.82M
Minimum
Dec 2023
-51.04M
Maximum
Sep 2019
-88.88M
Average
-99.49M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Tivic Health Systems Inc | -8.511M |
AIM ImmunoTech Inc | -21.27M |
Perspective Therapeutics Inc | -36.91M |
Protalix BioTherapeutics Inc | -1.318M |
Armata Pharmaceuticals Inc | -47.42M |